Efficacy Study of Recombinant Adenovirus for Non Muscle Invasive Bladder Cancer

Clinical trial NCT01438112 · TERMINATED

Trial details

NCT number: NCT01438112
Sponsor: CG Oncology, Inc.
Status: TERMINATED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Transitional Cell Carcinoma Bladder Cancer Carcinoma in Situ Carcinoma in Situ Concurrent With Papillary Tumors

Start date: 2014-03-01
Primary completion: 2016-06-01
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.